Xanthorrhoea‑type Hair Loss - Causes, Treatment & When to See a Doctor

```html

What is Xanthorrhoea‑type Hair Loss?

Xanthorrhoea‑type hair loss (sometimes abbreviated X‑type alopecia) is a descriptive term used by dermatologists to characterize a pattern of scalp hair loss that mimics the appearance of the Australian Xanthorrhoea plant—commonly known as the “grass tree.” The condition is marked by a sharply defined, often triangular or wedge‑shaped bald patch that originates at the fronto‑temporal hair line and expands outward, giving the scalp a “saw‑tooth” or “flame‑shaped” silhouette.

Unlike diffuse thinning, X‑type hair loss is usually focal, progresses slowly, and may be unilateral or bilateral. The term itself is not a diagnosis; rather, it describes the visual pattern produced by several underlying medical or environmental factors. Recognizing this pattern helps clinicians narrow the differential diagnosis and target appropriate testing.

Common Causes

Although the pattern is distinctive, many distinct disorders can produce Xanthorrhoea‑type hair loss. Below are eight of the most frequently encountered causes.

• Traction alopecia – Chronic pulling or tension from tight hairstyles (braids, ponytails, extensions).
• Frontal fibrosing alopecia (FFA) – A scarring alopecia that begins at the frontal hair line and can create a sharp, wedge‑shaped recession.
• Cutaneous lupus erythematosus (CLE) – Discoid lesions on the scalp can lead to scarring alopecia with angular borders.
Hereditary (androgenetic) alopecia – The classic “receding hair line” variant may occasionally assume a triangular shape in early stages.
• Secondary syphilis – The “moth‑eaten” alopecia can coalesce into larger, angular patches.
• Localized scleroderma (morphea) – Fibrotic plaques on the scalp replace hair follicles, resulting in sharp‑edged bald areas.
• Neuro‑cutaneous syndromes (e.g., linear epidermal nevus) – Segmental skin anomalies that follow Blaschko’s lines can produce wedge‑shaped hair loss.
• Scalp burns or radiation therapy – Damage to follicular units in a linear or triangular field.
• Infectious causes (tinea capitis, bacterial folliculitis) – When inflammation is focal, the resulting alopecia can take on an angular pattern.

Associated Symptoms

The appearance of X‑type hair loss often occurs alongside other clinical clues that help pinpoint the underlying cause.

• Scalp itching or burning – Common in inflammatory or infectious etiologies.
• Scaling, redness, or papules – Suggests dermatitis, lupus, or fungal infection.
• Pain or tenderness – May indicate active inflammation (e.g., lupus, scleroderma).
• Visible scarring (white, shiny tissue) – Sign of permanent follicular loss (scarring alopecia).
• Systemic signs – Fever, malaise, joint pain, or a rash elsewhere on the body could point toward systemic lupus or secondary syphilis.
• Hair shaft abnormalities – Brittle or broken hairs may accompany traction alopecia.
• Neurological symptoms – Numbness or tingling in the affected area can be seen with neuro‑cutaneous disorders.

When to See a Doctor

While occasional minor hair shedding is normal, the following situations warrant prompt medical evaluation:

• Rapid expansion of the bald patch (greater than 0.5 cm per month).
• Presence of pain, burning, or marked tenderness.
• Visible scarring, skin discoloration, or ulceration.
• Accompanying systemic symptoms (fever, joint pain, unexplained weight loss).
• History of autoimmune disease, recent infections, or exposure to radiation/chemical burns.
• Any concern that the hair loss may be irreversible.

Diagnosis

Accurate diagnosis relies on a stepwise approach that combines clinical observation with targeted testing.

1. Detailed History

• Onset, progression, and pattern of hair loss.
• Hair‑care practices, hairstyles, and recent changes.
• Personal or family history of autoimmune disease, skin disorders, or hair loss.
• Recent infections, medication use, or exposure to radiation/chemicals.

2. Physical Examination

• Inspection of the scalp for scaling, erythema, atrophy, or scar tissue.
• Dermoscopic (trichoscopic) evaluation – looks for follicular openings, perifollicular hemorrhage, black dots, or “exclamation‑mark” hairs.
• Examination of other skin, mucosal, and joint surfaces for systemic clues.

3. Laboratory Tests (selected based on suspicion)

• Complete blood count (CBC) and inflammatory markers (ESR, CRP).
• Autoantibodies: ANA, anti‑dsDNA, ENA panel (for lupus); anti‑Ro/La for Sjögren’s.
• Serology for syphilis (RPR/VDRL, treponemal test).
• Thyroid function tests (TSH, free T4) – hypothyroidism can mimic other alopecias.
• Fungal culture or KOH preparation if tinea capitis is suspected.

4. Scalp Biopsy

When the diagnosis remains unclear, a 4‑mm punch biopsy that includes subcutis is the gold standard. Pathology can differentiate between:

• Non‑scarring (e.g., telogen effluvium, alopecia areata) vs. scarring alopecia.
• Inflammatory pattern (lymphocytic, neutrophilic, eosinophilic).
• Fibrosis, perifollicular mucin, or interface dermatitis typical of lupus.

Treatment Options

Treatment must be individualized to the underlying cause, the extent of hair loss, and the patient’s preferences. Early intervention improves the chance of regaining hair density.

Medical Therapies

• Topical corticosteroids – 0.05–0.1% clobetasol propionate applied daily for inflammatory or early scarring alopecias (e.g., FFA, lupus).
• Intralesional corticosteroid injections – Triamcinolone acetonide (2.5–10 mg/mL) into the affected area every 4–6 weeks.
• Systemic anti‑inflammatories – Oral prednisone (0.5–1 mg/kg) for acute lupus or severe inflammatory alopecia, tapered over weeks.
• Antimalarials – Hydroxychloroquine 200–400 mg daily for chronic cutaneous lupus or FFA.
• Immunomodulators – Mycophenolate mofetil or methotrexate for refractory scarring alopecia.
• Antifungal agents – Oral terbinafine or griseofulvin for tinea capitis; topical antifungal shampoos as adjunct.
• Antibiotics – Doxycycline 100 mg bid for folliculitis‑related hair loss.
• Syphilis treatment – Benzathine penicillin G 2.4 MU IM weekly for 3 weeks (or alternative per CDC guidelines).
• Hair‑growth stimulators – Minoxidil 2% (women) or 5% (men) solution applied twice daily; works best when follicular units are still viable.

Procedural & Supportive Measures

• Low‑level laser therapy (LLLT) – FDA‑cleared devices may accelerate regrowth in non‑scarring scenarios.
• Platelet‑rich plasma (PRP) – In-office injections that deliver growth factors; evidence is modest but promising.
• Hair transplantation – Considered once disease activity is quiescent and scarring is stable.
• Scalp microneedling – Enhances topical absorption and may stimulate follicular proliferation.

Home & Lifestyle Interventions

• Gentle, sulfate‑free shampoos; avoid harsh chemicals or heat styling.
• Limit tension‑producing hairstyles; use loose braids or clips.
• Balanced diet rich in protein, iron, zinc, biotin, and omega‑3 fatty acids (e.g., fish, nuts, leafy greens).
• Stress‑reduction techniques: mindfulness, yoga, or moderate aerobic exercise.
• Stop smoking and limit alcohol – both impair microcirculation to hair follicles.

Prevention Tips

While some causes (autoimmune, genetic) cannot be prevented, many modifiable risk factors can be addressed:

• Adopt low‑tension hair practices – Avoid pulling, tight elastics, and excessive extensions.
• Protect scalp from UV radiation – Wear hats or use broad‑spectrum sunscreen on exposed scalp if you have a photosensitive disorder.
• Promptly treat skin infections – Early antifungal or antibacterial therapy prevents progression to scarring.
• Regular dermatology follow‑up if you have known autoimmune disease or prior alopecia.
• Maintain optimal nutrition – Iron deficiency anemia, zinc deficiency, and severe malnutrition are known hair‑loss precipitants.
• Avoid harsh chemical exposures – Limit frequent bleaching, perming, or chemical straightening.
• Monitor medication side‑effects – Certain drugs (e.g., retinoids, anticoagulants) can exacerbate scalp inflammation; discuss alternatives with your physician.

Emergency Warning Signs

Key Take‑aways

Xanthorrhoea‑type hair loss is a visual pattern rather than a single disease. Recognizing the characteristic wedge‑shaped bald area helps clinicians narrow down a diverse list of potential causes—from traction alopecia and frontal fibrosing alopecia to systemic lupus and infections. Early evaluation, appropriate laboratory or biopsy work‑up, and targeted therapy dramatically improve the odds of halting progression and achieving regrowth.

Because some underlying disorders (especially scarring alopecias) can become irreversible, anyone noticing a sharply defined patch of hair loss should consult a dermatologist promptly. With timely intervention, most patients can control inflammation, preserve existing follicles, and often stimulate new hair growth.

---

References (accessed May 2026):

• Mayo Clinic. “Hair loss.” Mayo Clinic Proceedings, 2023.
• American Academy of Dermatology. “Frontal Fibrosing Alopecia.” Clinical Guidelines, 2022.
• CDC. “Syphilis – Clinical Information.” 2024.
• NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases. “Lupus and Skin Manifestations.” 2023.
• Cleveland Clinic. “Traction Alopecia – Causes and Treatments.” 2024.
• WHO. “Guidelines for the Management of Cutaneous Fungal Infections.” 2022.

```